APDN — Applied DNA Sciences Cashflow Statement
0.000.00%
Last trade - 00:00- $5.79m
- -$3.71m
- $3.43m
- 12
- 56
- 11
- 15
Annual cashflow statement for Applied DNA Sciences, fiscal year end - September 30th, USD millions except per share, conversion factor applied.
2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | 2024 September 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -13 | -14.3 | -8.27 | -10 | -7.09 |
| Depreciation | |||||
| Non-Cash Items | 1.07 | 3.66 | -2.95 | -0.004 | -6.18 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.528 | -3.62 | 0.955 | 2.45 | -1.14 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -11.1 | -13.4 | -8.98 | -6.22 | -13.7 |
| Capital Expenditures | -1.06 | -2.55 | -0.49 | -1.14 | -0.408 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | — | — | — | 0.045 | 0 |
| Sale of Fixed Assets | |||||
| Cash from Investing Activities | -1.06 | -2.55 | -0.49 | -1.1 | -0.408 |
| Financing Cash Flow Items | 0 | — | — | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 19.4 | 14.7 | 18.1 | 0 | 13.4 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 7.23 | -1.23 | 8.66 | -7.31 | -0.721 |